Literature DB >> 4303482

Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3.

J W Blunt, Y Tanaka, H F DeLuca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4303482      PMCID： PMC225284          DOI： 10.1073/pnas.61.4.1503

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  Effect of various vitamin deficiencies on citric acid metabolism in the rat.

Authors:  H F De Luca; G Guroff; H Steenbock; S Reiser; M R Mannatt
Journal:  J Nutr       Date:  1961-10       Impact factor: 4.798

2.  Metabolism of tritiated vitamin D3 in familial vitamin D-resistant rickets with hypophosphatemia.

Authors:  H F DeLuca; J Lund; A Rosenbloom; C C Lobeck
Journal:  J Pediatr       Date:  1967-05       Impact factor: 4.406

3.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

4.  Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose.

Authors:  S J Stohs; H F DeLuca
Journal:  Biochemistry       Date:  1967-11       Impact factor: 3.162
  4 in total
  22 in total

1.  A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation.

Authors:  Nirupama K Shevde; Lori A Plum; Margaret Clagett-Dame; Hironori Yamamoto; J Wesley Pike; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

Review 2.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

Review 3.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

Review 4.  History of the discovery of vitamin D and its active metabolites.

Authors:  Hector F Deluca
Journal:  Bonekey Rep       Date:  2014-01-08

5.  Lag period of action of 25-hydroxycholecalciferol on bone collagen metabolism in vitamin D deficient rats.

Authors:  E Morava; R Tarjan; M Winter
Journal:  Experientia       Date:  1973-10-15

6.  Influence of disodium ethane-1-hydroxy-1,1-diphosphonate on vitamin D metabolism in rats.

Authors:  D von Herrath; K Schaefer; J P Bonjour; H Fleisch
Journal:  Pflugers Arch       Date:  1972       Impact factor: 3.657

7.  Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine.

Authors:  M F Holick; H K Schnoes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Effect of cortisone treatment on the active transport of calcium by the small intestine.

Authors:  D V Kimberg; R D Baerg; E Gershon; R T Graudusius
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

9.  Intestinal calcium absorption, serum phosphate, and parathyroid hormone in patients with chronic renal failure and osteodystrophy before and during hemodialysis.

Authors:  J R Juttmann; J C Hagenouw-Taal; L D Lameyer; A M Ruis; J C Birkenhäger
Journal:  Calcif Tissue Res       Date:  1978-12-08

10.  Vitamin D3-stimulated template activity of chromatin from rat intestine.

Authors:  R B Hallick; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.